- Report
- March 2020
- 40 Pages
United States
From €2501EUR$2,595USD£2,151GBP
- Report
- March 2020
- 40 Pages
South Korea
From €2501EUR$2,595USD£2,151GBP
- Report
- March 2020
- 40 Pages
Russia
From €2501EUR$2,595USD£2,151GBP
- Report
- March 2020
- 40 Pages
Japan
From €2501EUR$2,595USD£2,151GBP
- Report
- March 2020
- 40 Pages
Ireland
From €2501EUR$2,595USD£2,151GBP
- Report
- March 2020
- 40 Pages
Germany
From €2501EUR$2,595USD£2,151GBP
- Report
- March 2020
- 40 Pages
France
From €2501EUR$2,595USD£2,151GBP
- Report
- March 2024
- 132 Pages
Global
From €915EUR$950USD£787GBP
- Report
- January 2022
- 116 Pages
Global
From €4336EUR$4,500USD£3,730GBP
- Report
- April 2021
- 259 Pages
Global
From €5559EUR$5,769USD£4,782GBP
- Report
- September 2019
Global
From €5174EUR$5,370USD£4,451GBP
The Blood Culture Test is a type of infectious disease testing used to detect the presence of bacteria, fungi, or other microorganisms in the blood. It is used to diagnose and monitor the treatment of a variety of infections, including sepsis, endocarditis, and meningitis. The test involves collecting a sample of blood and culturing it in a laboratory to identify any microorganisms present. Results are typically available within 24 to 48 hours.
The Blood Culture Test market is a growing segment of the infectious disease testing industry. It is used in both clinical and research settings, and is increasingly being used to diagnose and monitor infections in the community. The market is driven by the increasing prevalence of infectious diseases, the need for rapid diagnosis, and the development of new technologies.
Companies in the Blood Culture Test market include Becton Dickinson, bioMérieux, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more